Literature DB >> 34541079

Formation of Minimised Hairpin Template-transcribing Dumbbell Vectors for Small RNA Expression.

Xiaoou Jiang1, Volker Patzel1.   

Abstract

A major barrier for using non-viral vectors for gene therapy is the short duration of transgene expression in postmitotic tissues. Previous studies showed transgene expression from conventional plasmid fell to sub-therapeutic level shortly after delivery even though the vector DNA was retained, suggesting transcription was silenced in vivo ( Nicol et al., 2002 ; Chen et al., 2004 ). Emerging evidence indicates that plasmid bacterial backbone sequences are responsible for the transcriptional repression and this process is independent of CpG methylation ( Chen et al., 2008 ). Dumbbell-shaped DNA vectors consisting solely of essential elements for transgene expression have been developed to circumvent these drawbacks. This novel non-viral vector has been shown to improve transgene expression in vitro and in vivo ( Schakowski et al., 2001 and 2007). Here we describe a novel method for fast and efficient production of minimised small RNA-expressing dumbbell vectors. In brief, the PCR-amplified promoter sequence is ligated to a chemically synthesized hairpin RNA coding DNA template to form the covalently closed dumbbell vector. This new technique may facilitate applications of dumbbell-shaped vectors for preclinical investigation and human gene therapy.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Dumbbell vector; Genetic therapy; Minimal vector; Small RNA expression; miRNA; shRNA

Year:  2017        PMID: 34541079      PMCID: PMC8410377          DOI: 10.21769/BioProtoc.2313

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  8 in total

1.  A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.

Authors:  F Schakowski; M Gorschlüter; C Junghans; M Schroff; P Buttgereit; C Ziske; B Schöttker; S A König-Merediz; T Sauerbruch; B Wittig; I G Schmidt-Wolf
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

2.  Small-interfering-RNA expression in cells based on an efficiently constructed dumbbell-shaped DNA.

Authors:  Masumi Taki; Yoshio Kato; Makoto Miyagishi; Yasuomi Takagi; Kazunari Taira
Journal:  Angew Chem Int Ed Engl       Date:  2004-06-14       Impact factor: 15.336

3.  Minimal size MIDGE vectors improve transgene expression in vivo.

Authors:  Frank Schakowski; Marcus Gorschlüter; Peter Buttgereit; Angela Märten; Marie V Lilienfeld-Toal; Claas Junghans; Matthias Schroff; Sven A König-Merediz; Carsten Ziske; John Strehl; Tilman Sauerbruch; Burghardt Wittig; Ingo G H Schmidt-Wolf
Journal:  In Vivo       Date:  2007 Jan-Feb       Impact factor: 2.155

4.  Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.

Authors:  Zhi-Ying Chen; Efren Riu; Chen-Yi He; Hui Xu; Mark A Kay
Journal:  Mol Ther       Date:  2008-02-05       Impact factor: 11.454

5.  Enzymatic ligation assisted by nucleases: simultaneous ligation and digestion promote the ordered assembly of DNA.

Authors:  Gregory J Cost
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

6.  Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA Expression.

Authors:  Xiaoou Jiang; Han Yu; Cui Rong Teo; Genim Siu Xian Tan; Sok Chin Goh; Parasvi Patel; Yiqiang Kevin Chua; Nasirah Banu Sahul Hameed; Antonio Bertoletti; Volker Patzel
Journal:  Mol Ther       Date:  2016-06-30       Impact factor: 11.454

7.  Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation.

Authors:  F Nicol; M Wong; F C MacLaughlin; J Perrard; E Wilson; J L Nordstrom; L C Smith
Journal:  Gene Ther       Date:  2002-10       Impact factor: 5.250

8.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.

Authors:  Z Y Chen; C Y He; L Meuse; M A Kay
Journal:  Gene Ther       Date:  2004-05       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.